Overview Financials News + Filings Key Docs Ownership
|
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F |
| Revenues: |
| JMC NT$000 | | | | | 1,667.8 | 1,588.2 | |
| JMC US$000 | | | | | 51.5 | | |
| Other | | | | | | 17,248.9 | |
| Total revenues | 21.2 | 10.8 | 8.4 | 0.0 | 567.5 | 18,837.1 | 20,829.0 |
| Revenue growth [+] | 96.6% | 28.2% | | -100.0% | -97.0% | -9.6% | |
| JMC NT$000 | | | | | 5.0% | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 455.1 | 14,685.5 | 15,716.5 |
| Gross profit | 21.2 | 10.8 | 8.4 | 0.0 | 112.4 | 4,151.6 | 5,112.5 |
| Gross margin | 100.0% | 100.0% | 100.0% | | 19.8% | 22.0% | 24.5% |
| Selling, general and administrative [+] | | | | | 27.6 | 860.4 | 809.1 |
| Sales and marketing | | | | | 2.2 | 90.3 | 96.3 |
| General and administrative | 0.0 | 0.0 | 0.0 | 0.0 | 25.4 | 770.1 | 712.8 |
| Research and development | | | | | 25.9 | 747.8 | 678.8 |
| Other operating expenses | 21.2 | 10.8 | 8.4 | | -2.8 | -105.1 | -26.2 |
| EBIT [+] | 0.0 | 0.0 | 0.0 | 0.0 | 61.7 | 2,648.5 | 3,650.8 |
| EBIT growth | | | | -100.0% | -97.7% | -27.5% | |
| EBIT margin | 0.0% | 0.0% | 0.0% | | 10.9% | 14.1% | 17.5% |
| Other income (expense), net | | | | | -9.2 | 197.6 | 1,052.1 |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 52.5 | 2,846.1 | 4,702.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | -5.5 | -935.9 | -1,036.2 |
| Minority interest | | | | | | 37.1 | 534.7 |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | 0.0% | 0.0% | 0.0% | | 0.0% | 0.0% | 0.0% |
| |
| Basic EPS | | | | | $0.00 | $0.00 | $0.00 |
| Diluted EPS | | | | | $0.00 | $0.00 | $0.00 |
| |
| Shares outstanding (basic) [+] | | | | | 859.6 | 877.4 | 858.7 |
| Growth | | | | | -2.0% | 2.2% | |
| Shares outstanding (diluted) [+] | | | | | 866.8 | 888.3 | 865.8 |
| Growth | | | | | -2.4% | 2.6% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|